Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Dagmar Adámková Krákorová"'
The risk of second primary malignancies in colorectal cancer patients using calcium channel blockers
Autor:
Jana Halámková, Lucia Bohovicová, Lucie Pehalová, Tomáš Kazda, Roman Goněc, Teodor Staněk, Lucie Mouková, Dagmar Adámková Krákorová, Šárka Kozáková, Marek Svoboda, Regina Demlová, Lucie Gabrielová, Lenka Hernychová, Igor Kiss
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract Calcium channel blockers are among the most commonly used agents in the treatment of cardiovascular diseases. There are several known side-effects associated with their long-term use, whereas other potential adverse effects are yet to be pro
Externí odkaz:
https://doaj.org/article/6d25c6199bb14f1786d61c2c93398684
Autor:
Michal Mahdal, Lukáš Pazourek, Vasileios Apostolopoulos, Dagmar Adámková Krákorová, Iva Staniczková Zambo, Tomáš Tomáš
Publikováno v:
Current Oncology, Vol 29, Iss 5, Pp 3519-3530 (2022)
Background: The purpose of this study was to evaluate the implant survival, functional score and complications of intercalary endoprostheses implanted for metastatic involvement of the femoral and humeral diaphysis. Methods: The selected group covere
Externí odkaz:
https://doaj.org/article/b0f452dea6804d71a803eace9ce6dafd
Autor:
Jana Halámková, Lucia Bohovicová, Lucie Pehalová, Roman Goněc, Teodor Staněk, Tomáš Kazda, Lucie Mouková, Dagmar Adámková Krákorová, Šárka Kozáková, Marek Svoboda, Regina Demlová, Igor Kiss
Publikováno v:
Cancers, Vol 14, Iss 7, p 1699 (2022)
An increasing number of studies has brought evidence of the protective role of statin use against different types of cancer. However, data on their association with second primary malignancies (SPMs) are lacking. The purpose of this study was to dete
Externí odkaz:
https://doaj.org/article/6e7ddf0a12b344d38bdead9675bcd6a5
Autor:
Kamila Říhová, Monika Dúcka, Iva Staniczková Zambo, Ladislava Vymětalová, Martin Šrámek, Filip Trčka, Jan Verner, Stanislav Drápela, Radek Fedr, Tereza Suchánková, Barbora Pavlatovská, Eva Ondroušková, Irena Kubelková, Danica Zapletalová, Štěpán Tuček, Peter Múdry, Dagmar Adámková Krákorová, Lucia Knopfová, Jan Šmarda, Karel Souček, Lubor Borsig, Petr Beneš
The transcription factor c-Myb is an oncoprotein promoting cell proliferation and survival when aberrantly activated/expressed, thus contributing to malignant transformation. Overexpression of c-Myb has been found in leukemias, breast, colon and aden
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84b04ff593300ff6bdf0cde2b3cfb8ff
https://www.zora.uzh.ch/id/eprint/226453/
https://www.zora.uzh.ch/id/eprint/226453/
Publikováno v:
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti. 34(4)
Paclitaxel is one of the most common cytostatics used in oncology; it is part of the therapeutic protocols of many malignancies. One of its most common side effects is peripheral neuropathy. This symptomatology often leads to a reduction in the dose
Autor:
Jiří Šedo, Renata Koukalová, Zuzana Šimková, Dagmar Adámková Krákorová, Petr Szturz, Pavel Fabian
Publikováno v:
Klinicka onkologie.
BACKGROUND At present, lung cancer ranks among the most frequent malignant diseases. However, according to literature data, mesenchymal lung tumors are very rare, representing less than 0.5% of all malignant lung tumours. Epithelioid hemangioendothel
Autor:
Štěpán Tuček, Pavel Janíček, Dagmar Adámková Krákorová, Katerina Kubackova, Jana Prausová, Iva Staniczková Zambo, Ladislav Dušek, Tomáš Tomáš, Igor Kiss
Publikováno v:
Pathology & Oncology Research. 24:623-630
Ewing sarcoma (ES) is an exceptionally rare tumor in adults. Data regarding outcomes of adult patients with ES and experiences with age-adapted therapeutic strategies are very limited. The aim of this study was to evaluate prognostic factors and clin
Autor:
Igor Kiss, S Tuček, Ondrej Bilek, Regina Demlová, Jana Halámková, Jan Kristek, Tomas Kazda, Iva Staniczková Zambo, Dagmar Adámková Krákorová
Publikováno v:
Medicine
Rationale: The Ewing sarcoma family of malignant tumors is a group of tumors characterized by morphologically similar round-cell neoplasms and by the presence of a common chromosomal translocation; Ewing sarcoma family of tumors typically occur in ch
Publikováno v:
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti. 31(3)
Mesenchymal malignancies are relatively rare tumors with distinct behaviors that are usually surgically removal. However, it is sometimes impossible to perform such surgery according to standardized procedures. In particular, surgical removal of intr
Publikováno v:
Journal of the Czech & Slovak Societies for Oncology / Klinická Onkologie; 2018, Vol. 31 Issue 3, p230-234, 5p